RetinalGenix Technologies (RTGN) Shareholder's Equity (2020 - 2026)
RetinalGenix Technologies (RTGN) Shareholder's Equity (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shareholder's Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.92 Bn | 146.27 Bn | 6.27 Bn | 52.06 Bn |
| 2 | Stryker | 119.50 Bn | 116.62 Bn | 3.81 Bn | 22.98 Bn |
| 3 | Medtronic | 102.71 Bn | 94.54 Bn | 5.76 Bn | 49.20 Bn |
| 4 | Boston Scientific | 69.72 Bn | 68.51 Bn | 3.61 Bn | 26.10 Bn |
| 5 | Edwards Lifesciences | 49.24 Bn | 45.57 Bn | 1.29 Bn | 10.33 Bn |
| 6 | GE HealthCare Technologies | 29.74 Bn | 27.67 Bn | 1.98 Bn | 10.67 Bn |
| 7 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 13.34 Bn |
| 8 | Dexcom | 28.96 Bn | 27.84 Bn | 750.30 Mn | 2.96 Bn |
| 9 | Steris | 20.31 Bn | 19.88 Bn | 697.10 Mn | 7.20 Bn |
| 10 | RetinalGenix Technologies | - | - | - | -2.56 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -2.56 Mn |
| Dec 31, 2025 | -2.30 Mn |
| Sep 30, 2025 | -2.17 Mn |
| Jun 30, 2025 | -1.98 Mn |
| Mar 31, 2025 | -1.67 Mn |
| Dec 31, 2024 | -1.46 Mn |
| Sep 30, 2024 | -1.85 Mn |
| Jun 30, 2024 | -1.81 Mn |
| Mar 31, 2024 | -1.52 Mn |
| Dec 31, 2023 | -1.41 Mn |
| Sep 30, 2023 | -1.08 Mn |
| Jun 30, 2023 | -1.77 Mn |
| Mar 31, 2023 | -1.50 Mn |
| Dec 31, 2022 | -1.07 Mn |
| Sep 30, 2022 | -1.06 Mn |
| Jun 30, 2022 | -675,175.00 |
| Mar 31, 2022 | -724,323.00 |
| Dec 31, 2021 | -464,675.00 |
| Sep 30, 2021 | -412,708.00 |
| Jun 30, 2021 | -35,742.00 |